|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 04, 2016 ) Cancer that starts from hematopoietic stem cells of the bone marrow is referred to as leukemia. Leukemia can be chronic or acute depending on the maturity of the cells. Also, based on the bone marrow cells from which cancer starts, leukemia can be categorized as lymphocytic or myeloid.
Technavios analysts forecast the leukemia therapeutics market to grow at a CAGR of 8.44% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the leukemia therapeutics market for 2016-2020. To calculate the market size, the report considers the the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of different types of leukemias.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=825379
Technavio's report, Leukemia Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
F. Hoffmann-La Roche
Novartis
Bristol-Myers Squibb
AbbVie
Teva Pharmaceuticals
Other prominent vendors
Altor BioScience
Amgen
ARIAD Pharmaceuticals
Arno Therapeutics
Astex Pharmaceuticals
AstraZeneca
Baxter Healthcare
Bayer HealthCare
Bellicum Pharmaceuticals
Biogen
Boehringer Ingelheim
BioLineRx
Boston Biomedical
Celator Pharmaceuticals
Celgene
CTI BioPharma
Chroma Therapeutics
Chugai Pharmaceutical
Cyclacel Pharmaceuticals
Daiichi Sankyo
Eisai
Emergent BioSolutions
Erytech Pharma
Fate Therapeutics
Genzyme
Gilead Sciences
GlaxoSmithKline
iDD biotech
Immune Pharmaceuticals
Immunomedics
Infinity Pharmaceuticals
Innate Pharma
Jazz Pharmaceuticals
Juno Therapeutics
Karyopharm Therapeutics
Ligand Pharmaceuticals
MEDA Pharmaceuticals
MedImmune
Merck
Midas Pharma
Molecular Templates
MorphoSys
Nippon Shinyaku
Novo Nordisk
Onconova Therapeutics
Ono Pharmaceuticals
Orphan Europe
Otsuka
Pfizer
Portola Pharmaceuticals
Regeneron Pharmaceuticals
Sanofi
Sigma-Tau Pharmaceuticals
Stemline Therapeutics
Sunesis Pharmaceuticals
TG Therapeutics
TheraMAB
Tolero Pharmaceuticals
XEME Biopharma
Xencor
ZIOPHARM Oncology
Market driver
Technological advances in the monitoring of leukemia
For a full, detailed list, view our report
Market challenge
Limitations associated with current therapeutic options
For a full, detailed list, view our report
Market trend
Rise in the development of combination therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=825379
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
